Trade: The Brokers Issue Forecasts for Citigroup Inc.’s Q1 2017 Earnings (C)

Trade: The Brokers Issue Forecasts for Citigroup Inc.’s Q1 2017 Earnings (C)

Citigroup Inc. (NYSE:C) – Investment analysts at Jefferies Group lowered their Q1 2017 earnings estimates for Citigroup in a research note issued on Monday. Jefferies Group analyst K. Usdin now anticipates that the brokerage will post earnings per share of $1.37 for the quarter, down from their prior estimate of $1.38. Jefferies Group has a “Buy” rating and a $58.00 price target on the stock. Jefferies Group also issued estimates for Citigroup’s Q2 2017 earnings at $1.32 EPS, Q3 2017 earnings at $1.31 EPS and FY2017 earnings at $5.20 EPS….

Trade: The Teacher Retirement System of Texas Boosts Stake in Kennametal Inc. (KMT)

Trade: The Teacher Retirement System of Texas Boosts Stake in Kennametal Inc. (KMT)

Teacher Retirement System of Texas boosted its stake in Kennametal Inc. (NYSE:KMT) by 13.9% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 11,074 shares of the company’s stock after buying an additional 1,348 shares during the period. Teacher Retirement System of Texas’ holdings in Kennametal were worth $245,000 at the end of the most recent reporting period. A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase &…

Trade: The Omeros Corporation (OMER) Receives Outperform Rating from FBR & Co

Trade: The Omeros Corporation (OMER) Receives Outperform Rating from FBR & Co

FBR & Co restated their outperform rating on shares of Omeros Corporation (NASDAQ:OMER) in a report released on Tuesday morning. They currently have a $38.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the stock. Maxim Group reiterated a buy rating and issued a $19.00 target price on shares of Omeros Corporation in a research note on Tuesday. Cantor Fitzgerald reiterated a buy rating and issued a $21.00 target price on shares of Omeros Corporation in a research note on…

Trade: The Progenics Pharmaceuticals Inc. (PGNX) Given Buy Rating at Jefferies Group

Trade: The Progenics Pharmaceuticals Inc. (PGNX) Given Buy Rating at Jefferies Group

Jefferies Group restated their buy rating on shares of Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) in a research note issued to investors on Tuesday. They currently have a $10.00 price target on the stock, up from their prior price target of $9.00. PGNX has been the subject of several other reports. Brean Capital set a $14.00 price target on Progenics Pharmaceuticals and gave the stock a buy rating in a research note on Friday, August 5th. Zacks Investment Research upgraded Progenics Pharmaceuticals from a sell rating to a hold rating in a…

Trade: The Spectrum Pharmaceuticals Inc. (SPPI) Upgrade to Buy by The Zacks Investment Research

Trade: The Spectrum Pharmaceuticals Inc. (SPPI) Upgrade to Buy by The Zacks Investment Research

Zacks Investment Research upgraded shares of Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) from a hold rating to a buy rating in a research report report published on Tuesday. The firm currently has $4.50 price target on the biotechnology company’s stock. According to Zacks, “Spectrum focuses in the fields of hematology and oncology. Its multiple myeloma drug Evomela, launched in the second quarter of 2016, is off to an encouraging start with strong formulary access and solid adoption in top institutions. Evomela sales are expected to go up in the second half of…

Trade: The Synacor Inc. (SYNC) Now Covered by Analysts at Ladenburg Thalmann

Trade: The Synacor Inc. (SYNC) Now Covered by Analysts at Ladenburg Thalmann

Ladenburg Thalmann started coverage on shares of Synacor Inc. (NASDAQ:SYNC) in a report released on Tuesday morning. The firm issued a buy rating on the stock. Shares of Synacor (NASDAQ:SYNC) opened at 2.95 on Tuesday. Synacor has a 52 week low of $1.30 and a 52 week high of $3.98. The firm has a 50-day moving average of $2.86 and a 200 day moving average of $2.74. The firm’s market cap is $89.36 million. Synacor (NASDAQ:SYNC) last announced its earnings results on Wednesday, August 3rd. The company reported ($0.09) EPS…

Trade: The Del Taco Restaurants Inc. (TACO) Price Target Raised to $16.00 at BTIG Research

Trade: The Del Taco Restaurants Inc. (TACO) Price Target Raised to $16.00 at BTIG Research

Del Taco Restaurants Inc. (NASDAQ:TACO) had its price objective boosted by BTIG Research from $14.00 to $16.00 in a research note published on Tuesday morning. The brokerage currently has a buy rating on the stock. Several other research analysts have also commented on TACO. Zacks Investment Research raised Del Taco Restaurants from a sell rating to a hold rating in a research report on Saturday, June 25th. Jefferies Group reissued a buy rating and issued a $14.00 price objective (down from $16.00) on shares of Del Taco Restaurants in a…

Trade: The Tecnoglass Inc. (TGLS) Upgrade to Hold at The Zacks Investment Research

Trade: The Tecnoglass Inc. (TGLS) Upgrade to Hold at The Zacks Investment Research

Zacks Investment Research upgraded shares of Tecnoglass Inc. (NASDAQ:TGLS) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning. According to Zacks, “Tecnoglass, Inc. is engaged in manufacturing and selling architectural glass and windows and aluminum products for the residential and commercial construction industries. It operates primarily in North, Central and South America. Tecnoglass, Inc., formerly known as Andina Acquisition Corporation, is headquartered in Barranquilla, Colombia. “ Shares of Tecnoglass (NASDAQ:TGLS) opened at 11.68 on Tuesday. Tecnoglass has a 12 month low…

Trade: The Nevro Corp (NVRO) Lowered by The Zacks Investment Research to “Hold”

Trade: The Nevro Corp (NVRO) Lowered by The Zacks Investment Research to “Hold”

Zacks Investment Research downgraded shares of Nevro Corp (NASDAQ:NVRO) from a strong-buy rating to a hold rating in a research note published on Tuesday. According to Zacks, “Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and…

Trade: The Newtek Business Services Inc. (NEWT) Decreased to Sell at The Zacks Investment Research

Trade: The Newtek Business Services Inc. (NEWT) Decreased to Sell at The Zacks Investment Research

Zacks Investment Research lowered shares of Newtek Business Services Inc. (NASDAQ:NEWT) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. According to Zacks, “Newtek Capital, Inc. resulted from the combination of the businesses previously owned by BJB Holdings, Inc. and REXX Environmental Corporation and is operating as a holding company for a network of partner companies in a collaborative and coordinated effort to develop successful businesses in a number of existing as well as emerging, technological business lines. “ A number…